Company · EVGN
Evogene Ltd.
Nasdaq's symbol directory lists EVGN on Nasdaq as “Evogene Ltd. - Ordinary Shares”.
In the 12 months to Nov 8, 2026: insiders bought on 3 occasions ($693K); 12 filings by holders of 5% or more.
Insider trades · SEC Form 4
Those inside the hall
Open-market purchases and sales only. Legs one person filed for one day are combined.
Who traded
- RECANATI LEON bought $692K
- Tarcic Gabi, Chief Development Officer bought $677
Every trade (3)
- BUYRECANATI LEON bought $292K
- BUYRECANATI LEON bought $400K
- BUYTarcic Gabi, Chief Development Officer bought $677
Large holders · SEC Schedules 13D and 13G
Five percent and over
Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G
- L.I.A. Pure Capital Ltd. 16.94%
- L.I.A. Pure Capital Ltd. 19.35%
- RECANATI LEON 8.6%
- L.I.A. Pure Capital Ltd 19.35%
- Armistice Capital, LLC 4.99%
- L.I.A. Pure Capital Ltd 19.35%
- RECANATI LEON 8.6%
- RECANATI LEON 5.7%
- L.I.A. Pure Capital Ltd 15.98%
- L.I.A. Pure Capital Ltd 17.41%
- L.I.A. Pure Capital Ltd 16.81%
- L.I.A. Pure Capital Ltd 12.61%
Sources: SEC EDGAR (Forms 4 and 144) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.